Related Experiment Videos
CD16+ NK lymphoproliferative disorders: cellular and molecular characterization.
Natural Immunity and Cell Growth Regulation
|January 1, 1987
Summary
This study identifies a rare CD16+ lymphoproliferative disorder, potentially a natural killer (NK) cell leukemia. The findings suggest a distinct lineage separate from T cells in affected patients.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Investigating rare CD16+ lymphoproliferative disorders.
- Characterizing aberrant cell surface markers in affected individuals.
Observation:
- Mononuclear cells in two patients showed over 80% CD16+ expression, alongside CD2+, CD7+, but lacked CD3, CD4, and CD8.
- One patient's cells expressed HLA-DR and HLA-DQ, with significant natural killer (NK) cell activity against K562 targets.
- Karyotype analysis revealed a chromosome 6 deletion, indicating clonal expansion.
Findings:
- Southern blot analysis confirmed the T cell receptor beta-chain was in germ line configuration.
- This supports a clonal expansion of NK cells, distinct from T cells.
- The disorder is proposed as a true natural killer (NK) cell leukemia.
Implications:
- This research expands the understanding of lymphoproliferative disorders.
- It highlights the potential for a distinct NK cell leukemia.
- Further research into this rare condition is warranted for diagnostic and therapeutic advancements.